International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

Russia flag Russia · Delayed Price · Currency is RUB
672.00
-1.50 (-0.22%)
At close: Jul 8, 2022
-1.10%
Market Cap 10.03B
Revenue (ttm) 326.74M
Net Income (ttm) 132.03M
Shares Out 14.93M
EPS (ttm) 8.84
PE Ratio 75.99
Forward PE n/a
Dividend 8.65 (1.29%)
Ex-Dividend Date n/a
Volume 90
Average Volume 778
Open 666.00
Previous Close 673.50
Day's Range 666.00 - 674.00
52-Week Range 601.00 - 1,250.00
Beta 0.25
RSI 38.85
Earnings Date Jul 25, 2025

About MOEX:GEMA

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a personal stem cell storage bank in Russia. The company is involved in the personal storage of stem cells and development of drugs for the treatment of blood and immune system diseases. It stores biomaterial samples in its database for long-term personal storage, including samples of hematopoietic cord blood stem cells, as well as samples of mesenchymal stem cells and umbilical cord tissue for transplant. The company was founded in 20... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 2003
Employees 15
Stock Exchange Moscow Stock Exchange
Ticker Symbol GEMA
Full Company Profile

Financial Performance

In 2023, MOEX:GEMA's revenue was 283.51 million, an increase of 11.32% compared to the previous year's 254.68 million. Earnings were 125.78 million, an increase of 28.13%.

Financial Statements

News

There is no news available yet.